EAZIFLO D TABLET may cause excessive drowsiness with alcohol.
Information regarding the use of EAZIFLO D TABLET during pregnancy is not available. Please consult your doctor.
Information regarding the use of EAZIFLO D TABLET during breastfeeding is not available. Please consult your doctor.
EAZIFLO D TABLET may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
There is limited information available on the use of EAZIFLO D TABLET in patients with kidney disease. Please consult your doctor.
EAZIFLO D TABLET should be used with caution in patients with liver disease. Dose adjustment of EAZIFLO D TABLET may be needed. Please consult your doctor. Use of EAZIFLO D TABLET is not recommended in patients with severe liver disease.
If you miss a dose of EAZIFLO D TABLET, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More